Antibiotics are widely used in veterinary and human health system worldwide. Although the present achievements of development in both health sectors are due to the use of antibiotics, there is a big challenge of combating antimicrobial resistance in the future to be faced by human civilization. The phenomenon of antimicrobial resistance is a common problem of both developed and developing worlds. World Health Organization (WHO) has publicly announced to the science community for the better antibiotic drugs discovery as soon as possible. The research on various disciplines related to antibiotics and antimicrobial resistance is advancing around the globe. In Nepal, antibiotic drug discovery research projects are being continued with the national fund provided by university grants commission, and government of Nepal. More than two hundred researchers including University Professors, postdoctoral researchers, PhD students and other researchers from various public and private organizations- universities, research centers, and hospitals are working in this field under various research projects in Nepal. This is a part of UN SDG 3 contribution. Currently, the organizers of this conference are also engaged in the field of antibiotic drug discovery research project with the grants of University Grants Commission Nepal. Prof. Harald Gross from Tuebingen University is also collaborating with us in the project. The AvH foundation has also supported similar research project under the digital cooperation fellowship to Dr. Babita Paudel-Bhattarai. Therefore, this conference aims to bring together leading national and international experts, researchers, healthcare professionals and policymakers to discuss the latest updates on AMR and the development of new antibiotics. The event will provide a common platform for sharing new research ideas, innovative solutions achieved so far, research collaboration opportunities of both national and international level to combat AMR effectively.
The conference will feature the mixture of keynote session, oral presentation, poster presentation, panel discussion and academic visit of delegates to universities, research laboratories etc. All the presentations are of plenary type.
Following types of audiences will be present in the conference:
This conference will serve as a critical platform for advancing the global fight against AMR. By bringing together diverse stakeholders from several countries, we aim to foster innovation, collaboration and action to address one the most pressing public health challenges of our time.
From Green Algae to Tuberculosis and COVID-19: Journey of a non-conformist biologist
National Science Chair, Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, New Delhi, India; and Distinguished Professor, Sharda University, Noida-NCR, India
Ingenious Nature: Antibacterial Natural Products with elaborate Modes of Action
National Science Chair, Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, New Delhi, India; and Distinguished Professor, Sharda University, Noida-NCR, India
Assault, Siege, Trojan Horses or Gentle Disarmament: Molecular Strategies to Fight Drug-Resistant Bacterial Infections
Helmholtz Centre for Infection Research, Braunschweig, Germany; German Centre of Infection Research, Site Hannover-Braunschweig, Germany
Uridyl- and Lipo-Peptides Reloaded – New Insights into their Biosynthesis and Mode(s) of Action
Pharmaceutical Institute, Department of Pharmaceutical Biology, University of Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany